SIBN News and Press, SI-BONE Inc. From 04/29/19

­ SANTA CLARA, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 Bank of America Merri...

SANTA CLARA, Calif., April 24, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2019 after market close on...

SANTA CLARA, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based medical device company dedicated to solving musculoskeletal disorders of the spinopelvic anatomy, today announced that it received an additional 510(k) clearance from the U.S. Food a...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The first powerhouse round of earnings arrives as nearly every sector has a major p...

April 15, 2019 concludes the 180-day lockup period of Si-Bone Inc. ( SIBN ). When the lockup period ends for Si-Bone Inc., its pre-IPO shareholders and company insiders will have the opportunity to sell more than 15.7 million currently-restricted shares. This number dwarfs the 7.2 million...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year tests of the top three forensic algorithms used to detect bankruptcy risk, earnings manipulation, and financial irregularities. My forward testing compiles portfolio...

SI-BONE, Inc. (SIBN) Q4 2018 Results Earnings Conference Call March 07, 2019 08:00 AM ET Company Participants Carrie Mendivil - Gilmartin Group Jeffrey Dunn - CEO Laura Francis - CFO Conference Call Participants David Lewis - Morgan Stanley David Turkaly - JMP Securities...

SI-BONE (NASDAQ: SIBN ): Q4 GAAP EPS of -$0.26 misses by $0.06 . More news on: SI-BONE, Earnings news and commentary, Healthcare stocks news, Read more ...

SANTA CLARA, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today reported financial results for the three months and full year e...